In-Licensing

Noviscend is seeking to expand its product portfolio in Canada. Our business development activities are focused on diagnotic products and medical devices that are in late-stage development, or currently approved and commercialized outside Canada, or approved in Canada but falling outside the license holder’s business focus. We will consider in-licensing, acquisition, co-promotion, revenue-sharing, and other partnering opportunities.

Therapeutic categories of primary interest for proprietary products include oncology, neurology, psychiatry, dermatology, pain management, and women's health, although we may consider other opportunities outside of these areas.

For partnering inquiries please contact us.